Enf Vii (b) L.p. Mdv, 10% Owner at Adamas Pharmaceuticals Inc (ADMS), sold 28,837 shares at $27.55 ($794K) on 2015-07-08, disclosed to the SEC on 2015-07-09.
Scheduled sale ($794k) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.55 | 25,737 | $709K | 89.2% |
| 2 | $27.55 | 3,100 | $85K | 10.8% |
| Total | $27.55 avg | 28,837 | $794K | 100% |
| Filing → |